The integrity of our genomes is under continual assault from errors generated during replication, metabolically produced reactive oxygen species, spontaneous depurination, and endogenous and exogenous agents that damage DNA. Replication stress and DNA damage activate checkpoint signaling pathways that help maintain gemonic stability by orchestrating DNA repair, gene transcription, and cell cycle arrest. A critical check point signaling pathway is the Atr-Chkl signaling pathway, which is activated by replication stress and other types of DNA damage and plays an important role in maintaining genomic stability. Key partcipants in the Atr-Chkl signaling pathway are Rad9, Husl, and Radl, which form a Rad9- Husl-Radl (911) complex, and are required for optimal Chkl activation as well as other cellular responses to DNA damage. The 911 complex forms a PCNA-like clamp that is loaded around DNA at sites of damage. Although the clamp is loaded around DNA and is required for optimal Chkl activation, the clamp's actual role in Chkl activation and orchestrating other cellular events remains unknown.
In Aim 1 of this proposal, we have identified a novel Rad9-interacting protein that binds the C terminus of Rad9, a region required for Chkl activation, and we propose to examine the role of this interacting protein on Rad9 function and Chkl activation.
In Aim 2, we describe Rad9B, a new Rad9 paralog, and demonstrate that Rad9, Rad9B, Husl, HuslB (a Husl paralog), and Radl combinatorially assemble into different clamps. We then propose to examine the roles of each subunit in cellular responses to a panel of genotoxic agents to identify whether each 911 subunit has unique and/or overlapping roles.
In Aim 3, we show that the 911 complex interacts with a translesion DNA polymerase and we propose experiments to examine the role of 911 subunits in translesion polymerase function. Collectively, these studies will provide new insights into how the 911 complexes direct downstream events that regulate checkpoint activation, cell survival, and genomic stability. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA084321-06
Application #
6948624
Study Section
Special Emphasis Panel (ZRG1-CDF-2 (90))
Program Officer
Pelroy, Richard
Project Start
1999-12-01
Project End
2009-04-30
Budget Start
2005-08-19
Budget End
2006-04-30
Support Year
6
Fiscal Year
2005
Total Cost
$265,500
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Karnitz, Larry M; Zou, Lee (2015) Molecular Pathways: Targeting ATR in Cancer Therapy. Clin Cancer Res 21:4780-5
Schenk, Erin L; Koh, Brian D; Flatten, Karen S et al. (2012) Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro. Clin Cancer Res 18:5364-73
Huehls, Amelia M; Wagner, Jill M; Huntoon, Catherine J et al. (2012) Identification of DNA repair pathways that affect the survival of ovarian cancer cells treated with a poly(ADP-ribose) polymerase inhibitor in a novel drug combination. Mol Pharmacol 82:767-76
Huehls, Amelia M; Wagner, Jill M; Huntoon, Catherine J et al. (2011) Poly(ADP-Ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells. Cancer Res 71:4944-54
Geng, Liyi; Huehls, Amelia M; Wagner, Jill M et al. (2011) Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil. PLoS One 6:e28862
Wagner, Jill M; Karnitz, Larry M (2009) Cisplatin-induced DNA damage activates replication checkpoint signaling components that differentially affect tumor cell survival. Mol Pharmacol 76:208-14
Leonard, Jennifer M; Ye, Hong; Wetmore, Cynthia et al. (2008) Sonic Hedgehog signaling impairs ionizing radiation-induced checkpoint activation and induces genomic instability. J Cell Biol 183:385-91
Delacroix, Sinny; Wagner, Jill M; Kobayashi, Masahiko et al. (2007) The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev 21:1472-7
Karnitz, Larry M; Flatten, Karen S; Wagner, Jill M et al. (2005) Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival. Mol Pharmacol 68:1636-44
Hackbarth, Jennifer S; Lee, Sun-Hee; Meng, Xue Wei et al. (2004) S-peptide epitope tagging for protein purification, expression monitoring, and localization in mammalian cells. Biotechniques 37:835-9

Showing the most recent 10 out of 15 publications